Details for New Drug Application (NDA): 209074

NDA 209074 describes MINOXIDIL (FOR WOMEN), which is a drug marketed by Aurobindo Pharma, P And L, Taro, Apotex Inc, Aurobindo Pharma Ltd, Hikma, L Perrigo Co, and Sight Pharms, and is included in nine NDAs. It is available from thirty-seven suppliers. Additional details are available on the MINOXIDIL (FOR WOMEN) profile page.

The generic ingredient in MINOXIDIL (FOR WOMEN) is minoxidil. There are eight drug master file entries for this compound. Eighty-six suppliers are listed for this compound. Additional details are available on the minoxidil profile page.

Summary for 209074

Tradename:	MINOXIDIL (FOR WOMEN)
Applicant:	Taro
Ingredient:	minoxidil
Patents:	0

Pharmacology for NDA: 209074

Physiological Effect

Arteriolar Vasodilation

Medical Subject Heading (MeSH) Categories for 209074

Antihypertensive Agents

Vasodilator Agents

Suppliers and Packaging for NDA: 209074

Tradename	Generic Name	Dosage	NDA	Application Type	Supplier	National Drug Code	Package Code	Package
MINOXIDIL (FOR MEN)	minoxidil	AEROSOL, FOAM;TOPICAL	209074	ANDA	Walgreen Company	0363-9090	0363-9090-01	1 CAN in 1 CARTON (0363-9090-01) / 60 g in 1 CAN
MINOXIDIL (FOR MEN)	minoxidil	AEROSOL, FOAM;TOPICAL	209074	ANDA	Walgreen Company	0363-9090	0363-9090-03	3 CAN in 1 CARTON (0363-9090-03) / 60 g in 1 CAN

Profile for product number 001

Active Rx/OTC/Discontinued:	OTC	Dosage:	AEROSOL, FOAM;TOPICAL			Strength	5%
Approval Date:	Dec 31, 2018	TE:		RLD:	No

Profile for product number 002

Active Rx/OTC/Discontinued:	OTC	Dosage:	AEROSOL, FOAM;TOPICAL			Strength	5%
Approval Date:	Apr 22, 2019	TE:		RLD:	No

Complete Access Available with Subscription